A Randomized, Single blinded, Placebo controlled Clinical Study to Assess the Efficacy and Safety of MEERA Anti Dandruff powder in patients suffering from dandruff disorders

CavinKare Private Limited0 个研究点目标入组 40 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Male and female subjects who are 18 to 45 years of age.
•2. Subjectssuffering from Dandruff of scalp
•3. Subjects who are committed not to use medicated/non medicated shampoos/soaps (including soaps containing antibacterial/antifungal agents) or any other antidandruff treatment/hair products (including prescription and non-prescription medications such as hair oil, conditioners) for the entire duration of the study.
•4. Subject usually using a shampoo 3 times a week and accepting to follow this rate during the whole study period.
•5. Subjects not have participated in any other clinical trial during the past 3 months.

•1. Scalp Psoriasis.
•2. Subjects who underwent any type of hair procedures within the past 2 weeks or during the study.
•3. Subjects with immediate life threatening diseases such as pre-existing cardiovascular, liver or neoplastic disease.
•4. Subjects undergoing treatment for immune-compromised conditions/psychiatric illness.
•5. Subjects with any other co- morbid conditions like Diabetes that can affect the study outcome.
•6. Pregnant or lactating women.
•7. Hypersensitivity to any of the components of the test formulation.
•8. The presence of any other condition that leads the investigator to conclude that the patient is inappropriate for inclusion in this clinical study.

发起方